PAI
BLUE

Pittenger & Anderson Inc’s bluebird bio BLUE Stock Holding History

Pittenger & Anderson Inc’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed -$1K – 370
2019
Q3 		$1K Hold
1
– – ﹤0.01% 353
2019
Q2 		$1K Hold
1
– – ﹤0.01% 358
2019
Q1 		$2K Hold
1
– – ﹤0.01% 360
2018
Q4 		$1K Hold
1
– – ﹤0.01% 353
2018
Q3 		$2K Hold
1
– – ﹤0.01% 358
2018
Q2 		$2K Hold
1
– – ﹤0.01% 367
2018
Q1 		$2K Hold
1
– – ﹤0.01% 360
2017
Q4 		$2K Hold
1
– – ﹤0.01% 381
2017
Q3 		$1K Buy
+1
New +$1.4K ﹤0.01% 370

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pittenger & Anderson Inc's BLUE Position: Q4 2019 in Review

Pittenger & Anderson Inc sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 1 share — an estimated $1K sold.

Pittenger & Anderson Inc first reported a position in BLUE in Q3 2017 and held it in 9 quarters. The position peaked at $2K in Q1 2019. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • Pittenger & Anderson Inc reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 1 bluebird bio share in Q4 2019, an estimated $1K.
  • Pittenger & Anderson Inc first reported a position in bluebird bio in Q3 2017 and held it in 9 quarters.
  • Pittenger & Anderson Inc's bluebird bio position peaked at $2K in Q1 2019.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2019, filed 12 Feb 2020.